跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lexzin IV - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lexzin IV
Approved
STANDARD
Lexzin IV
Akums Drugs & Pharmaceuticals Ltd. (Plant III-Injectables)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a6e7650d2f8b5745
Company
Akums Drugs & Pharmaceuticals Ltd. (Plant III-Injectables)
Type
Standard
Approval Details
Approval Id
a6e7650d2f8b5745
Drug Approval Philippines Name
Lexzin IV
Product Name
Lexzin IV
Registration Number
DRP-3937-04
Brand Name
Lexzin IV
Generic Name
Levofloxacin (as hemihydrate)
Dosage Form
Solution for Intravenous Infusion
Dosage Strength
5mg/ mL (500mg/ 100mL)
Manufacturer
Akums Drugs & Pharmaceuticals Ltd. (Plant III-Injectables)
Importer
Ambica International Corporation
Distributor
STARPHARM, INC.
Issuance Date
27 May 2022
Expiry Date
04 September 2027
Pharmacologic Category
Antibacterial (Quinolone)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a6e7650d2f8b5745
Type
Standard
Back to Philippines FDA Approvals